Tang et al. [43] reported that there is no correlation between the rs11615 polymorphism of the ERCC1 gene and the chemosensitivity of platinum drugs in ovarian cancer, which is inconsistent with our conclusion. This evidence concerns the gene ERCC1 and ovarian carcinoma.